You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p53 mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Aug 4, 2022

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022

p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome

Completed
  • Mitochondrial Disorders
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 18, 2021

    MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • Sodium stibogluconate
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    Jun 5, 2021

    Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)

    Recruiting
    • Refractory Solid Tumors
    • Arsenic trioxide
    • Shanghai, China
      Department of Oncology, Ruijin Hospital
    May 11, 2021

    P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

    Recruiting
    • P53 Mutation
    • +3 more
    • Shanghai, Shanghai, China
      Hematological department, Shanghai Institute of Hematology, Ruij
    Apr 20, 2021

    Endometrial Cancer, Serous Tumor, P53 Mutation Trial in Toronto (Cisplatin, External Beam Radiation, Carboplatin)

    Recruiting
    • Endometrial Cancer
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 20, 2021

    Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Los Angeles, California
    • +10 more
    Aug 12, 2022

    Li Fraumeni Syndrome Trial in Villejuif (whole body MRI)

    Completed
    • Li Fraumeni Syndrome
    • whole body MRI
    • Villejuif, France
      Institut Gustave Roussy
    Feb 23, 2021

    Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

    Active, not recruiting
    • Adult Solid Neoplasm
    • +16 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Mar 17, 2022

    Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

    Not yet recruiting
    • Pediatric Cancer
    • +2 more
    • Arsenic trioxide
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Oct 12, 2023

    Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,

    Active, not recruiting
    Has Results
    • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
    • Gilbert, Arizona
    • +19 more
    Aug 23, 2022

    Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

    Completed
    • Leukemia, Lymphocytic, Chronic
    • Dresden, Germany
    • +10 more
    Jan 13, 2023

    Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

    Not yet recruiting
    • Aumolertinib
    • +4 more
    • (no location specified)
    Mar 8, 2023

    Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)

    Terminated
    • Colorectal Cancer Metastatic
    • +2 more
    • Bergen, Norway
      Haukeland University Hospital
    Jan 20, 2021

    Ovarian Cancer, Endometrial Cancer Trial in Shanghai (Arsenic trioxide for injection)

    Recruiting
    • Ovarian Cancer
    • Endometrial Cancer
    • Arsenic trioxide for injection
    • Shanghai, Shanghai, China
      Shanghai JiaoTong University School of Medicine affliated Ruijin
    Jul 25, 2020

    Chronic Lymphocytic Leukemia Trial (Zebutinib&BR or Zebutinib&FCR)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Zebutinib&BR or Zebutinib&FCR
    • (no location specified)
    Jul 27, 2021

    Unusual Infiltrative Patterns of Malignant Cells in Endometrial

    Not yet recruiting
    • Endometrial Cancer
      • (no location specified)
      Mar 11, 2023

      Barrett's Oesophagus Trial in Cambridge (Cytosponge test, Assessment of the panel of molecular biomarkers: IM-SCORE, TFF3

      Recruiting
      • Barrett's Oesophagus
      • Cytosponge test
      • +2 more
      • Cambridge, United Kingdom
        MRC Cancer Unit
      Nov 3, 2020

      Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

      Not yet recruiting
      • Relapsing-remitting Multiple Sclerosis
      • CT-P53
      • +2 more
      • (no location specified)
      Jun 7, 2023

      SNPs in p53 and p53 Response Elements on Inflammatory Response

      Completed
      • HIV-1 Seropositive
      • +3 more
        • Research Triangle Park, North Carolina
          NIEHS Clinical Research Unit (CRU)
        Jan 21, 2023

        P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

        Completed
        • Endometrial Cancer
        • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
        • Alexandria, Egypt
          Hossam Hassan El Sokkary
        Sep 13, 2022

        Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • Aurora, Colorado
        • +55 more
        Jan 30, 2023

        Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Zanubrutinib plus RCHOP
        • Wuhan, Hubei, China
          Union Hospital, Tongji Medical College, Huazhong University of S
        Aug 16, 2023

        Infiltrating Duct Carcinoma of the Breast

        Not yet recruiting
        • Invasive Breast Cancer
          • (no location specified)
          Jan 28, 2023